Prot #R475-PN-1227: A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of REGN475 in Patients with Osteoarthritis of the Knee/Hip who have an Inadequate Response to NSAID and Opioid Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date6/22/156/22/18

Funding

  • Parexel (Prot #R475-PN-1227)
  • Regeneron Pharmaceuticals, Inc. (Prot #R475-PN-1227)